Gliclazid Spirig HC Retard 60 mg
Gliclazid Spirig HC Retard 60 mg is a medicine authorised by Swissmedic under authorisation number 65441. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 09 June 2015 and the authorisation is valid without a time limit. ATC code A10BB09 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 65441 |
|---|---|
| Name | Gliclazid Spirig HC Retard 60 mg |
| Full name | Gliclazid Spirig HC Retard 60 mg, Tabletten mit veränderter Wirkstofffreisetzung |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BB09 |
| First authorisation | 09 June 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Gliclazid Spirig HC Retard 60 mg, Tabletten mit veränderter Wirkstofffreisetzung | B | 09 June 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | A10BB09 | 07.06.2. | B |
| 2 | 60 | Tablette(n) | A10BB09 | 07.06.2. | B |
| 3 | 90 | Tablette(n) | A10BB09 | 07.06.2. | B |
| 4 | 120 | Tablette(n) | A10BB09 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Gliclazid Spirig HC Retard 60 mg authorised in Switzerland?
Yes. Gliclazid Spirig HC Retard 60 mg is authorised by Swissmedic under authorisation number 65441, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Gliclazid Spirig HC Retard 60 mg have?
Gliclazid Spirig HC Retard 60 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Gliclazid Spirig HC Retard 60 mg?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.